Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 288-297
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.288
Table 4 Patient comorbidities and management with associated mortality
VariableMortality overall (n = 58362)Mortality teaching (n = 30382)Mortality non-teaching (n = 27979)
Elixhauser comorbidities
04202 (7.2)3008 (9.9)1455 (5.2)
14085 (7.0)2734 (9.0)1287 (4.6)
24144 (7.1)2886 (9.5)1371 (4.9)
≥ 33794 (6.5)2157 (7.1)1567 (5.6)
Liver comorbidities
Alcoholic cirrhosisa4494 (7.7)2795 (9.2)1763 (6.3)
Ascites5953 (10.2)3585 (11.8)2266 (8.1)
Hepatic encephalopathy9338 (16.0)5165 (17.0)3973 (14.2)
SBP11322 (19.4)8294 (27.3)1567 (5.6)
Hepatorenal syndrome23695 (40.6)12335 (40.6)11415 (40.8)
Coagulopathy4844 (8.3)2917 (9.6)1931 (6.9)
Hepatocellular carcinoma7821 (13.4)4770 (15.7)2266 (8.1)
Management
Blood transfusion4319 (7.4)2643 (8.7)1735 (6.2)
Balloon tamponade30290 (51.9)15616 (51.4)14857 (53.1)
Portosystemic shunt8871 (15.2)5195 (17.1)2770 (9.9)